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INITIAL HEART RATE VARIABILITY COULD HELP 
TO IDENTIFY THE PATIENTS WITH MYOTONIC 
DYSTROPHY AT RISK OF DEATH
J.-D. LUPORSI 1, P. KAMINSKY 2, B. BREMBILLA-PERROT 1
1 Cardiologie, CHU de Brabois, Vandœuvre-lès-Nancy, France
2 Service des maladies orphelines, CHU de Brabois, Vandœuvre-
lès-Nancy, France
Heart rate variability evaluation (HRV) is used to evaluate the prognosis 
in heart diseases at risk of cardiac mortality. Myotonic dystrophy (MD) 
is complicated by cardiac involvement. The purpose of the study 
was to evaluate the prognostic value of HRV determination for the 
strati cation risk in MD.
Methods — 60 asymptomatic patients, 26 men, 34 women, mean 
age 39±12 years at inclusion, had a MD. The studies were performed 
at inclusion and repeated 4±2.5 years later. Recording of 24 hour 
Holter monitoring and measurement of HRV in the time domain was 
calculated every 5 minutes (Elatec system); standard deviation of 
mean RR intervals (SDNN) was determined. Left ventricular ejection 
fraction (LVEF) was evaluated by 2D echocardiography.
Results — 1 — General changes of studies: LVEF tended to decrease 
(63±8, 61.5±19.5 %) (p< 0.06). Mean values of SDNN did not 
change between the  rst inclusion (129±41 ms) and the last study 
(134±51 ms).
2 — Modi cations of studies according to initial data: LVEF was normal 
in 56 patients at inclusion. And decreased at second study 64±6 %, 
61.5±7 % (p<0.01). LVEF was less than 50 % in 4 patients at inclusion 
and did not change at second study (43.5±7 vs 45±8 %). At inclusion, 
SDNN was normal in 42 patients (>100 ms) (147±35 ms) and was 148±52 
at second study (NS); SDNN was < 100 ms in 2 of them at second study. 
SDNN was decreased (50 to 100 ms) in 17 patients at inclusion (mean 
85±9 ms) and tended to increase at second study (97±34 ms) (NS).
3 — Follow-up: Initial SDNN could be predictive of the mortality: four 
patients died from heart and respiratory failure ; Three had an initial 
SDNN < 100 ms (3/17 ; 18 %) and the last one had a normal SDNN (1/42 ; 
2 %) (p < 0.08).
Conclusions — The modi cations of HRV during the follow-up were not 
useful for the prediction of the adverse events in myotonic dystrophy, 
although LVEF decreased with time. However, a relatively low HRV at 
the  rst evaluation could be predictive of increasing mortality from 
2 to 18 %.
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EXTRACELLULAR CARDIAC MATRIX BIOMARKERS 
IN PATIENTS WITH ACUTE MYOCARDIAL 
INFARCTION COMPLICATED BY LEFT VENTRICULAR 
DYSFUNCTION AND HEART FAILURE: INSIGHTS 
FROM THE EPHESUS STUDY
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3 P zer Inc, New York, USA
4 Department of Internal Medicine, Division of Cardiology, 
University of Michigan, Ann Arbor, USA
5 Department of Cardiology, Heart Failure and Hypertension Unit, 
CHU Nancy, Nancy, France
Background — Aldosterone stimulates cardiac collagen synthesis. 
Circulating biomarkers of collagen turnover provide a useful 
tool for the assessment of cardiac remodelling in patients with 
congestive heart failure (CHF) and left ventricular systolic 
dysfunction (LVSD) post acute myocardial infarction (AMI).
Methods and Results — In a substudy of EPHESUS, which evaluated 
the effects of the selective aldosterone-receptor antagonist 
eplerenone versus placebo, serum levels of collagen biomarkers 
were measured in 476 patients with CHF following AMI complicated 
with LVSD. Combination of both ICTP and BNP levels above median 
at baseline was associated with all cause mortality and composite 
endpoint CV death or HF hospitalisation with hazard ratios of 
2.49 (p = 0.039) and 3.03 (p = 0.002) respectively. During follow 
up, PINP and PIIINP levels were found consistently lower in the 
eplerenone group and signi cantly so from month 6 onwards.
Conclusions — Changes in biomarkers of collagen synthesis and 
degradation suggest that extra cellular matrix remodelling is an 
active process in patients with CHF and LVSD post-AMI. High ICTP 
when combined with high BNP serum levels are associated with 
the highest event rate. Eplerenone suppresses post-AMI collagen 
turn over changes.
Keywords: acute myocardial infarction, extracellular matrix, 
collagen biomarkers, heart failure  
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TIME DEPENDENT ACTIVATION OF AKT-GSK3BETA 
AND CALCINEURIN SIGNALING PATHWAYS DURING 
THE DEVELOPMENT OF TAC-INDUCED LEFT 
VENTRICULAR HYPERTROPHY IN B6D2/F1 MICE
M. PREVILON 1, C. DACHEZ 1, J.-J. MERCADIER 1,2, P. ROUET-
BENZINEB 1
1 Inserm UMR 698, Paris, France
2 AP-HP, Groupe Hospitalier Bichat-Claude Bernard, Paris, 
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Left ventricular hypertrophy (LVH) is an adaptive response to 
chronic biomechanical stress that later progresses to maladaptive 
hypertrophy and heart failure. To better understand the 
mechanisms responsible for LVH development, we studied the 
activation of two major kinases, protein kinase B (Akt/PKB) 
and glycogen synthase kinase3b (GSK3b) and of a phosphatase, 
calcineurin (Cn) in an experimental model of thoracic aorta 
constriction (TAC).
Methods — 4 week-old B6D2/F1 male, Sham-operated (Sham) and 
TAC mice were studied 3, 7, 15, 30 and 60 days post-TAC. Gene 
expression and activation of signalling pathways was studied by 
PCR and Western Blot.
Results — TAC-induced LVH (10 — 51 % at days 3-60, respectively) 
was associated with: 1) fetal gene reexpression characterised by 
an increase in mRNA levels of BNP (1.7-3 fold) and a-SK (2-4 fold), 
an a- to b-MHC switch seen at day 30 only ; 2) a signi cant increase 
in SERCA2a (1.7 fold), PLB, and NCX (3.6 fold) protein levels at 
day 7. 3) a 2 fold increase in P-Akt at day 3 and a decrease at 
day 15 while Akt was increased at days 7 and 15 ; 4) an increase 
in P-GSK3b at day 15 (1.5 fold), whereas no change in Akt and 
GSK3b protein levels were seen at days 30 and 60 ; 5) a signi cant 
decrease in CnAb at day 15 (2 fold).
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Conclusion — LVH develops progressively from day 3 in response 
to TAC, accompanied by re-expression of the fetal gene program. 
The alpha to beta-MHC mRNA switch occurs late, associated with 
the transition to HF, which occurs progressively with time. At days 
3 and 15, P-Akt acts as an upstream regulator of GSK3b which may 
favour the development of LVH. 7 days post-TAC, a SERCA2a and NCX 
increase might contribute to decrease free cytosolic calcium level. 
At day 15, a further increase in LVH is associated with an increase 
in Cn activity and an increase GSK3b, which may counteract the 
hypertrophic response. Taken together, our data suggest a time-
dependent cross-talk between Cn and GSK3b to modulate cardiac 
hypertrophic response to pressure overload.
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L’ADMINISTRATION CHRONIQUE DE BRADYKININE 
RESTAURE LA FONCTION ENDOTHÉLIALE 
VASCULAIRE DANS UN MODÈLE CANIN 
DE LA DYSTROPHIE MUSCULAIRE DE DUCHENNE
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La dystrophie musculaire de Duchenne est causée par des 
mutations du gène de la dystrophine. Elle est caractérisée par 
la dégénérescence des  bres musculaires striées conduisant 
aux défaillances locomotrice, respiratoire et cardiaque. Le 
chien Golden Retriever est un modèle spontané de dystrophie 
musculaire (GRMD) où la mutation intéresse l’intron 6 du gène 
de la dystrophine. Alors que les altérations fonctionnelles et 
moléculaires des muscles striés (squelettiques et caediaques) ont 
été bien décrites, celles qui concernent la fonction endothéliale 
vasculaire le sont moins. Ainsi, nous avons examiné s’il existait 
une dysfonction endothéliale vasculaire et étudié l’effet d’une 
perfusion chronique de bradykinine, dont nous avons démontré 
qu’elle exerçait des effets protecteurs vasculaires dans un 
modèle d’insuf sance cardiaque indépendamment de tout effet 
presseur. Huit chiens GRMD (âge : 13 ± 1 mois) présentant une 
altération de la fonction systolique ventriculaire gauche (fraction 
de raccourcissement : 30 ± 3 %) ont été inclus et comparés à des 
chiens contrôles (n = 8 ; 38 ± 2 %, p < 0,05). Tous les animaux ont 
reçu pendant 4 semaines une perfusion de solution physiologique 
(solvant) ou de bradykinine (1 g/min) par un cathéter auriculaire 
gauche chroniquement implanté. Au terme du traitement, les 
artères coronaires ont été prélevées. L’acétylcholine (ACh, 10-
10 — 10-4M) a entrainé une relaxation concentration-dépendante 
de l’artère coronaire circon exe pré-contractée par l’U46619 (1 
mmol/L) chez les chiens contrôles ayant reçu le solvant ou la 
BK. Cette réponse a été quasiment abolie chez les chiens GRMD 
ayant reçus le solvant (n = 3), indiquant une altération grave 
de la fonction endothéliale coronaire. En revanche, après un 
traitement chronique par la bradykinine (n = 5), cette relaxation 
des artères coronaires de chiens GRMD a été restaurée à hauteur 
de 70 % de celle observée chez les chiens contrôles. Des résultats 
similaires ont été observés pour les anneaux de l’artère fémorale 
pré-contractés par la noradrénaline (0,3 mmol/L). Ainsi, chez les 
chiens GRMD, en plus de la dystrophie musculaire squelettique 
et de la dysfonction cardiaque, il existe une dysfonction 
endothéliale coronaire et fémorale majeure. L’administration 
chronique de bradykinine permet de restaurer en grande partie la 
vasodilatation endothélium-dépendante.
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CLONAL ANALYSIS OF THE ORIGIN OF 
THE VENTRICULAR CONDUCTION SYSTEM
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The cardiac conduction system (CS) controls the generation and 
propagation of electrical activity through the heart to coordinate 
cardiac contraction. This system is composed of specialized 
cardiomyocytes divided in de ned structures including the sinoatrial 
node, the atrio-ventricular node (AVN), the His bundle, bundle 
branches and peripheral Purkinje  bers. Nevertheless, despite the 
clinical importance of the conduction system in regulating cardiac 
rhythm its developmental origin is controversial.
A retrospective clonal analysis was performed in order to establish 
the lineage relationship between cells of the ventricular CS and 
the surrounding working myocardium. The α-cardiac actinnlaacZ 
clonal analysis mouse line was crossed with the Cx40-eGFP 
transgenic line in which cells of the conduction system are 
readily detectable. Clonally related clusters of β-galactosidase 
positive myocytes containing GFP positive cells were scored 
in 3 week old hearts. The presence of hearts with large clones 
demonstrates that the entire ventricular CS originates from a pool 
of early progenitors during the dispersive growth phase of cardiac 
development. The analysis of clonally related clusters reveals the 
existence of two types of cluster underlying a common mode of 
development for the different components of the ventricular CS. 
A  rst step of differentiation/induction from a common progenitor 
with contractile cardiomyocytes is followed by proliferation of 
commited conductive cells. Our data suggest that cells of the 
central components (AVN, HIS) of the ventricular CS segregate 
early during development while differentiation of the peripheral 
CS occurs over an extended period of time. Furthermore, our study 
reveals different modes of growth for Purkinje  bers in the right 
and left ventricles that appear to be correlated with the different 
morphological properties of the ventricles. Our analysis provides 
new insights into previous controversies existing in the literature 
concerning the mode of development of the ventricular CS. Detailed 
understanding of ventricular CS formation is an important issue 
given that ventricular arrhythmias are major factors of morbidity 
and mortality and can result from defects in ventricular conduction 
system development.
